ArticleThe British journal of ophthalmology2004
Colour vision testing as an aid to diagnosis and management of age related maculopathy.
Article in The British journal of ophthalmology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 56 citations in OpenAlex.
- Effects of idebenone on color vision in patients with leber hereditary optic neuropathy.Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society · 2013Trial
- A randomized placebo-controlled trial of idebenone in Leber's hereditary optic neuropathy.Brain : a journal of neurology · 2011Trial
- Comparison of colour contrast sensitivity in eyes at high risk of neovascular age-related macular degeneration with and without subsequent choroidal neovascular membrane development.Eye (London, England) · 2023Article
- Alterations of color vision and pupillary light responses in age-related macular degeneration.Frontiers in aging neuroscience · 2022Article
- Weeklong improved colour contrasts sensitivity after single 670 nm exposures associated with enhanced mitochondrial function.Scientific reports · 2021Article
- Simple Vision Function Tests that Distinguish Eyes with Early to Intermediate Age-related Macular Degeneration.Ophthalmic epidemiology · 2021Article
- Colour vision deficiency and sputum colour charts in COPD patients: an exploratory mixed-method study.NPJ primary care respiratory medicine · 2021Article
- Enhanced S-Cone Syndrome: Spectrum of Clinical, Imaging, Electrophysiologic, and Genetic Findings in a Retrospective Case Series of 56 Patients.Ophthalmology. Retina · 2021Article
- Colour contrast sensitivity in eyes at high risk of neovascular age-related macular degeneration.European journal of ophthalmology · 2020Article
- Quantifying Color Vision Changes Associated With Cataracts Using Cone Contrast Thresholds.Translational vision science & technology · 2020Article
- Use of the King-Devick Variable Color Contrast Sensitivity Chart to differentiate stages of age-related macular degeneration.BMJ open ophthalmology · 2020Article
- Blue-yellow dyschromatopsia in toluene-exposed workers.International archives of occupational and environmental health · 2019Article
- New iPAD-based test for the detection of color vision deficiencies.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2018Article
- Cone photoreceptor macular function and recovery after photostress in early non-exudative age-related macular degeneration.Clinical ophthalmology (Auckland, N.Z.) · 2018Article
- The burden of neovascular age-related macular degeneration: a patient's perspective.Clinical ophthalmology (Auckland, N.Z.) · 2018Article
- Color vision and neuroretinal function in diabetes.Documenta ophthalmologica. Advances in ophthalmology · 2015Article
- Early age-related macular degeneration impairs tolerance to stimulus degradation.Optometry and vision science : official publication of the American Academy of Optometry · 2010Article
- Safety monitoring in bevacizumab (Avastin) treatment: retinal function assessed by psychophysical (visual fields, colour vision) and electrophysiological (ERG/EOG) tests in two subgroups of patients.International ophthalmology · 2008Article
- Spare the rod and spoil the eye.The British journal of ophthalmology · 2005Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimTo provide a simple test that detects the onset of age related maculopathy (ARM), and can be used to monitor its severity.
methodsColour contrast sensitivity was measured using computer graphics techniques. Colour thresholds were measured along tritan and protan colour confusion axes in the presence of dynamic luminance noise. Thresholds were determined separately for two sizes of optotypes (6.5 degrees and 1.5 degrees). Natural pupils were used. Normal values for the test have been established.
resultsIn all patients with unilateral age related macular degeneration, the smaller optotype was invisible in that eye and in almost all, the larger optotype could not be seen. In the symptomless fellow eyes (with ARM) the larger optotype thresholds were raised. The degree of loss was larger for tritan. For the smaller optotype, protan thresholds were elevated in the majority of patients. Tritan losses were greater and disproportionate to the loss seen with the larger optotype. Every person including those with minimal fundal changes had tritan test results for 1.5 degree optotypes >2 SD above the normal mean. Tritan thresholds varied with the severity of the ARM.
conclusionsThe test is sensitive, simple and quick to administer, and easy for patients. Therefore, it should be useful in detecting and monitoring elderly people with age related changes in their fundi before irreversible loss of vision has occurred.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.